A movement to promote and conduct research on the treatment and prevention of drug-resistant tuberculosis (DR-TB) and provide access to effective cure and prevention of DR-TB throughout the world.

Over ten million people will develop tuberculosis (TB) in the world this year; over 500,000 of these will have multidrug-resistant tuberculosis (MDR-TB). Some will receive treatment. However, we know little about the best ways of treating drug-resistant TB (DR-TB) and preventing tuberculosis in people who come in contact with DR-TB patients. TB control efforts require new evidence-based knowledge about optimal treatment regimens, prophylaxis, and regimens involving new TB drugs in order to address the growing health threats of MDR-TB and extensively drug-resistant (XDR) TB.

Sign up for our monthly newsletter and review of recent literature!

To view our most recent newsletter click here!

 


Developments in MDR-TB


The 50th Union World Conference on Lung Health Flyer is Here!

Posted on 10/11/19

The 50th Union World Conference on Lung Health will be held from 30 October to 2 November 2019 in Hyderabad, India. RESIST-TB has summarized a list of symposia, oral abstracts, and workshops relating to drug-resistant tuberculosis (DR-TB) from the online programme in order to create this flyer.

Please view the flyer here!

For more news, click here.